Response and therapeutic failure to meglumine antimoniate, the first-line drug for cutaneous leishmaniasis infections in Colombian soldiers. [PDF]
Pavia PX +6 more
europepmc +1 more source
Zoonotic trypanosomatids in small mammals at a wildlife-urban interface in southeastern Brazil: Implications for transmission risk. [PDF]
Madureira ACC +15 more
europepmc +1 more source
Lipid Mediators in Host-Pathogen Interactions during <i>Leishmania</i> Infection: Friends or Foes? [PDF]
Andrade YMFS +7 more
europepmc +1 more source
LAMP-coupled CRISPR-Cas12a assays: A promising new tool for molecular diagnosis of leishmaniasis. [PDF]
Dueñas E +9 more
europepmc +1 more source
Immunopeptidomics of cutaneous leishmaniasis patients reveals the natural antigenic landscape. [PDF]
de Vrij N +24 more
europepmc +1 more source
<i>Crithidia fasciculata</i> Shows Non-Pathogenic Behavior in Leishmania Co-Infection Related to Temperature Stress, In Vitro and In Vivo Infections, and Amphotericin B Susceptibility. [PDF]
Santos JFBD +10 more
europepmc +1 more source
<i>In vitro</i> and <i>in vivo</i> studies of dehydroxylated-isoquines and -isotebuquines against trypanosomatids: a preclinical drug candidate for treatment of cutaneous leishmaniasis. [PDF]
Romero AH +9 more
europepmc +1 more source
Easy Identification of <i>Leishmania (Leishmania) amazonensis</i> and <i>Leishmania (Viannia) braziliensis</i> Species by Using Fourier-Transform Infrared Spectroscopy and Machine Learning Algorithms. [PDF]
Oliveira VAS +7 more
europepmc +1 more source
Comparison of meglumine antimoniate versus miltefosine in the treatment of new world cutaneous leishmaniasis: a systematic review and meta-analysis. [PDF]
Vieira ACP, Lins FC, Baquião AC.
europepmc +1 more source
Annexin A1 downregulates <i>in vitro</i> IL-1<i>β</i> production in <i>L. braziliensis</i>-infected cells. [PDF]
Santos CP +4 more
europepmc +1 more source

